An experimental design for finding of minimum dosage of carbamazepine and valproate in preventing of seizure attacks

Pakistan Journal of Pharmaceutical Sciences

Volumn 22, Issue 2, 2009, Pages 180-183

  Samaei, Afshin ^a   Nobahar, Monir ^a   Vafaei, Abbas A ^a  

^a SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carbamazepine; Epilepsy; Seizure; Valproate

Indexed keywords

CARBAMAZEPINE; VALPROIC ACID; ANTICONVULSIVE AGENT;

ADULT; ARTICLE; CHEMICAL ANALYSIS; CHILD; DOSE RESPONSE; DRUG BLOOD LEVEL; GAS CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; SEIZURE; ADOLESCENT; BLOOD; DOSE CALCULATION; DRUG MONITORING; EPILEPSY;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DOSAGE CALCULATIONS; DRUG MONITORING; EPILEPSY; HUMANS; VALPROIC ACID;

EID: 65449142467     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Aminoff MJ, Greenberg DA and Simon RP (2005). Clinical Neurology, Sixth edition, New York, McGraw-Hill Co., pp.263-284.
2. Andreoli TE, Carpenter CJ, Grzggs R and Loscalzo J (2004). Cecil Essentials of medicine, Sixth edition, Philadelphia, WB. Sanders Co., p.1057.
3. Czapinski P and Terczynski A (1996). Open randomized comparative trial of sodium valproate and carbamazepine in Adult onset epilepsy. Neurol. Neurochir. Pol., 30(3): 419-426.
4. Hemingway C, Leary M, Riordan G, Schlegal B and Walker K (1999). The effect of carbamazepine and sodium valproate on the blood and serum values if children from a third-world environment. J. Child Neurol., 14(11): 751-753.
5. Hernandez-Fustes OJ, Marcourakis T and de Bittencourt PR (1999). The clinical relevance of serial determinations of plasma concentrations of Carbamazepine and sodium valproate. Rev. Neurol., 28(11): 1043-1047.
6. Jannuzzi G, Cian P, Fattore C, Gatti G, Monaco F and Perucca E (2000). A Multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring inpatients with newly diagnosed epilepsy. The Italian TDM Study group in Epilepsy. Epilepsia., 41(7): 919-920. (Pubitemid 30097069)
7. Kasper S, Braunwald E, Fauci AS, Hauser SL, Longo DL and Jameson JL (2005). Harrison's principles of internal medicine, 16th Edition, Vol.4, New York, McGrow-Hill Co., pp.2363-2372.
8. Marson AG and Chadwick DW (2001). New drug treatments for epilepsy. J. Neural. Neurosurg. Psychiatry, 70: 143-148.
9. Marson AG, Kadir ZA and Chadwick DW (1996). New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ, 313: 1169-1174. (Pubitemid 26381894)
10. Meyer FP Sauer I Staemmler U and Walther H (1990). Blood level profile of valproate administration under therapeutic conditions in children. Padiatr. Grenzgeb., 29(4): 325-330.
11. Minkova GD and Getova DP (2000). Influence of carbamazepine-10, 11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid. Folia Med., 42(3): 16-19.
12. Miura H (1990). Aspects of antiepileptic drug therapy in children. No To Hattatsu., 22(2): 154-159. (Pubitemid 20182499)
13. Miura H (2000). Developmental and therapeutic pharmacology of antiepileptic drugs. Epilepsia., 41(Suppl. 9): 2-6. (Pubitemid 32002743)
14. Nilsson L, Bergman U, Diwan V, Farahmand BY, Persson PG and Tomson T (2001). Antiepileptic drug therapy and its management in sudden unexpected death in epilepsy: a case-control study. Epilepsia., 42(5): 667-673. (Pubitemid 32453652)
15. Prevey ML, Delaney RC, Cramer JA, Cattanach L, Collins JF and Mattson B (1996). Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Groups. Arch. Neurol., 53(10): 1008-1016.
16. Ramsay RE, McManus DQ, Guterman A, Briggle TV, Vazquez D, Perchalski R, Yost RA and Wong P (1990). Carbamazepine metabolism in humans: Effect of concurrent anticonvulsant therapy. Ther. Drug Monit., 12(3): 235-241. (Pubitemid 20150887)
17. Rattya J, Vainionpaa L, Knip M, Lanning P and Isojaryi JL (1999). The effects of Valproate, Carbamazepine, and Oxcarbazepine on growth and sexual maturation in girls with epilepsy. Pediatrics, 103(3): 588-593. (Pubitemid 29274505)
18. Reynolds NC and Murthy VS (1989). Serum free levels and evaluation anticonvulsant drug interactions. Wis. Med. J., 88(12): 25-27.
19. Ronen GM, Streiner DL and Rosenbaum P (2003). Health-related quality of life in childhood epilepsy: Moving beyond seizure control with minimal adverse effects. Health and Quality of Life Outcomes, 1(36): 1-10.
20. Steinborn B and Galas-Zgorzalewicz B (2000). Therapeutic antiepileptic drug monitoring: thirteen years of experience in the laboratory of Clinical Neuropharmacology in the Chair and Department of developmental neurology. Neurol. Neurochir. Pol., 33(Suppl 1): 49-59.
21. Verrotti A, Basciani F, Trotta D, Pomilio MP, Morgese G and Chiarelli F (2002). Serumcopper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels inepileptic children before and after 1 year of sodium valproate and carbamazepine therapy. Epilepsy Res., 48(1-2): 71-75. (Pubitemid 34127718)